Poulton Stuart bought KPTI
October 15, 2025 · Form 4 insider transaction
Poulton Stuart bought 39,682 shares of Karyopharm Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
39,682
Price
$0.00
Total value
N/A
InsiderPoulton Stuart
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 15, 2025
Filing dateOctober 16, 2025
Shares owned after67,392
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on December 31, 2026.